Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes

被引:275
作者
Clemmons, David R. [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
Fat metabolism; Growth; Insulin resistance; Growth hormone; FACTOR-BINDING PROTEIN-3; C-REACTIVE PROTEIN; IMPROVES GLYCEMIC CONTROL; ACID-LABILE SUBUNIT; IGF-I; MUSCLE INSULIN; GLUCOSE-INTOLERANCE; LIPID-METABOLISM; OBESE SUBJECTS; GENE DELETION;
D O I
10.1016/j.ecl.2012.04.017
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Insulin-like growth factor-I (IGF-I) is closely related to insulin but has distinct metabolic actions. IGF-I is an important stimulant of protein synthesis in muscle, but it also stimulates free fatty acid use. The administration of IGF-I to patients with extreme insulin resistance results in improvement in glycemic control, and IGF-I is associated with lowering glucose and enhancing insulin sensitivity in Type 1 and Type 2 diabetes. However, patients with diabetes are also sensitive to stimulation of side effects in response to IGF-I. IGF-I coordinately links growth hormone and insulin actions and has direct effects on intermediary metabolism.
引用
收藏
页码:425 / +
页数:21
相关论文
共 103 条
[1]
Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process [J].
Adamo, Martin L. ;
Farrar, Roger P. .
AGEING RESEARCH REVIEWS, 2006, 5 (03) :310-331
[2]
The Role of Insulin-Like Growth Factor (IGF) Binding Protein-2 in the Insulin-Mediated Decrease in IGF-I Bioactivity [J].
Arafat, Ayman M. ;
Weickert, Martin O. ;
Frystyk, Jan ;
Spranger, Joachim ;
Schoefl, Christof ;
Moehlig, Matthias ;
Pfeiffer, Andreas F. H. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) :5093-5101
[3]
Polymorphism in the IGF-I gene: Clinical relevance for short children born small for gestational age (SGA). [J].
Arends, N ;
Johnston, L ;
Hokken-Koelega, A ;
van Duijn, C ;
De Ridder, M ;
Savage, M ;
Clark, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2720-2724
[4]
INCREASED PROTEOLYSIS OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 (IGFBP-3) IN NONINSULIN-DEPENDENT DIABETES-MELLITUS SERUM, WITH ELEVATION OF A 29-KILODALTON (KDA) GLYCOSYLATED IGFBP-3 FRAGMENT CONTAINED IN THE APPROXIMATELY 130-KDA TO 150-KDA TERNARY COMPLEX [J].
BANG, P ;
BRISMAR, K ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1119-1127
[5]
Increased p85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess [J].
Barbour, LA ;
Rahman, SM ;
Gurevich, I ;
Leitner, JW ;
Fischer, SJ ;
Roper, MD ;
Knotts, TA ;
Vo, Y ;
McCurdy, CE ;
Yakar, S ;
LeRoith, D ;
Kahn, CR ;
Cantley, LC ;
Friedman, JE ;
Draznin, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (45) :37489-37494
[6]
BAYNE ML, 1990, J BIOL CHEM, V265, P15648
[7]
EFFECT OF INSULIN ON THE INSULIN-LIKE GROWTH-FACTOR SYSTEM IN CHILDREN WITH NEW-ONSET INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BEREKET, A ;
LANG, CH ;
BLETHEN, SL ;
GELATO, MC ;
FAN, J ;
FROST, RA ;
WILSON, TA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1312-1317
[8]
The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system [J].
Boisclair, YR ;
Rhoads, RP ;
Ueki, I ;
Wang, J ;
Ooi, GT .
JOURNAL OF ENDOCRINOLOGY, 2001, 170 (01) :63-70
[9]
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system:: Results from a multicenter study [J].
Brabant, G ;
von zur Mühlen, A ;
Wüster, C ;
Ranke, MB ;
Kratzsch, J ;
Kiess, W ;
Ketelslegers, JM ;
Wilhelmsen, L ;
Hulthén, L ;
Saller, B ;
Mattsson, A ;
Wilde, J ;
Schemer, R ;
Kann, P .
HORMONE RESEARCH, 2003, 60 (02) :53-60
[10]
Brismar Kerstin, 1995, Progress in Growth Factor Research, V6, P449, DOI 10.1016/0955-2235(96)00006-3